BERTHELSEN SPENCER R Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$4.45M

Insider Activity of BERTHELSEN SPENCER R

According to the SEC Form 4 filings, BERTHELSEN SPENCER R, being in a position of

  1. director at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 16000 shares for $1.19M,
    over all time since 2012-05-21, has bought 0 shares, and sold 123310 shares for $5.65M.

Biography of BERTHELSEN SPENCER R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,193,2802100

Comparison of Insiders on Amount of Buys and Sells

2026-06-15SaleIonis Pharmaceuticals, Inc.
IONS
director
8,000
0.0048%
$73.49$587,920-26.05%
2026-06-01SaleIonis Pharmaceuticals, Inc.
IONS
director
8,000
0.0049%
$75.67$605,360-26.33%
2024-06-17SaleIonis Pharmaceuticals, Inc.
IONS
director
16,000
0.0111%
$40.29$644,640-11.91%
2021-06-23SaleIonis Pharmaceuticals, Inc.
IONS
director
15,000
0.0106%
$37.74$566,100-7.83%
2020-06-23SaleIonis Pharmaceuticals, Inc.
IONS
director
15,000
0.0109%
$58.76$881,400-11.28%
2019-06-24SaleIonis Pharmaceuticals, Inc.
IONS
director
20,310
0.0145%
$63.59$1.29M-6.42%
2018-06-25SaleIonis Pharmaceuticals, Inc.
IONS
director
20,700
0.0161%
$42.23$874,113+31.47%
2012-06-25SaleIonis Pharmaceuticals, Inc.
IONS
director
300
0.0003%
$11.49$3,448+20.76%
2012-05-22SaleIonis Pharmaceuticals, Inc.
IONS
director
17,269
0.0173%
$9.56$165,092+41.68%
2012-05-21SaleIonis Pharmaceuticals, Inc.
IONS
director
2,731
0.0027%
$9.40$25,671+42.51%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.